Senseera
Healthcare & Life Sciences
Recent Finacing
Seed
Recent Raise
$7.1M
Senseera is a liquid biopsy company that develops a platform for non-invasive disease detection and monitoring using chromatin epigenomics technology, with a focus on oncology, immunology, and metabolic diseases.
Focus Areas
Liquid biopsy
chromatin epigenomics
non-invasive detection
oncology diagnostics
immunology
metabolic diseases
Investors